1. Home
  2. USLM vs LQDA Comparison

USLM vs LQDA Comparison

Compare USLM & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USLM

United States Lime & Minerals Inc.

HOLD

Current Price

$109.84

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$42.38

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USLM
LQDA
Founded
1948
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.4B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
USLM
LQDA
Price
$109.84
$42.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
11
Target Price
$138.00
$41.00
AVG Volume (30 Days)
119.9K
930.9K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
0.19%
N/A
EPS Growth
23.22
51.81
EPS
1.06
N/A
Revenue
$144,435,000.00
$158,320,000.00
Revenue This Year
$27.25
$278.87
Revenue Next Year
$13.76
$57.13
P/E Ratio
$103.08
N/A
Revenue Growth
N/A
1031.18
52 Week Low
$94.41
$11.85
52 Week High
$141.44
$46.67

Technical Indicators

Market Signals
Indicator
USLM
LQDA
Relative Strength Index (RSI) 34.79 65.57
Support Level $107.82 $35.00
Resistance Level $129.37 $46.67
Average True Range (ATR) 6.32 1.65
MACD -2.53 0.46
Stochastic Oscillator 19.27 92.74

Price Performance

Historical Comparison
USLM
LQDA

About USLM United States Lime & Minerals Inc.

United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: